CN105859647B - 一种环氧合酶‑2抑制剂帕瑞昔布的制备方法 - Google Patents
一种环氧合酶‑2抑制剂帕瑞昔布的制备方法 Download PDFInfo
- Publication number
- CN105859647B CN105859647B CN201610352476.0A CN201610352476A CN105859647B CN 105859647 B CN105859647 B CN 105859647B CN 201610352476 A CN201610352476 A CN 201610352476A CN 105859647 B CN105859647 B CN 105859647B
- Authority
- CN
- China
- Prior art keywords
- preparation
- methyl
- triethylamine
- reaction
- diphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 title claims abstract description 6
- 229940093444 Cyclooxygenase 2 inhibitor Drugs 0.000 title abstract description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims abstract description 51
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 45
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000005286 illumination Methods 0.000 claims abstract description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 20
- 229910052741 iridium Inorganic materials 0.000 claims abstract description 18
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000395 magnesium oxide Substances 0.000 claims abstract description 16
- 150000005360 2-phenylpyridines Chemical class 0.000 claims abstract description 15
- VTWKXBJHBHYJBI-SOFGYWHQSA-N (ne)-n-benzylidenehydroxylamine Chemical compound O\N=C\C1=CC=CC=C1 VTWKXBJHBHYJBI-SOFGYWHQSA-N 0.000 claims abstract description 14
- 235000019441 ethanol Nutrition 0.000 claims abstract description 12
- LNPDTQAFDNKSHK-UHFFFAOYSA-N valdecoxib Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C1=CC=C(S(N)(=O)=O)C=C1 LNPDTQAFDNKSHK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960002004 valdecoxib Drugs 0.000 claims abstract description 10
- 238000001953 recrystallisation Methods 0.000 claims abstract description 9
- 238000000605 extraction Methods 0.000 claims abstract description 7
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000011114 ammonium hydroxide Nutrition 0.000 claims abstract description 6
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 6
- 239000012074 organic phase Substances 0.000 claims abstract description 3
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000000376 reactant Substances 0.000 claims abstract description 3
- ZXIRUKJWLADSJS-UHFFFAOYSA-N 5-methyl-3,4-diphenyl-1,2-oxazole Chemical class CC=1ON=C(C=2C=CC=CC=2)C=1C1=CC=CC=C1 ZXIRUKJWLADSJS-UHFFFAOYSA-N 0.000 claims description 33
- 229940111134 coxibs Drugs 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- PGMVMQKSOQOICN-UHFFFAOYSA-N 2-phenyl-1,5-dihydropyrazole Chemical class C1=CCNN1C1=CC=CC=C1 PGMVMQKSOQOICN-UHFFFAOYSA-N 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 238000012805 post-processing Methods 0.000 abstract description 2
- GHUURDQYRGVEHX-UHFFFAOYSA-N prop-1-ynylbenzene Chemical compound CC#CC1=CC=CC=C1 GHUURDQYRGVEHX-UHFFFAOYSA-N 0.000 abstract description 2
- UAVZKRLWYOSHHP-UHFFFAOYSA-N 3,4-diphenyl-1,2-oxazole Chemical compound C=1ON=C(C=2C=CC=CC=2)C=1C1=CC=CC=C1 UAVZKRLWYOSHHP-UHFFFAOYSA-N 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- MILUBEOXRNEUHS-UHFFFAOYSA-N iridium(3+) Chemical compound [Ir+3] MILUBEOXRNEUHS-UHFFFAOYSA-N 0.000 description 7
- 229960003925 parecoxib sodium Drugs 0.000 description 5
- ICJGKYTXBRDUMV-UHFFFAOYSA-N trichloro(6-trichlorosilylhexyl)silane Chemical compound Cl[Si](Cl)(Cl)CCCCCC[Si](Cl)(Cl)Cl ICJGKYTXBRDUMV-UHFFFAOYSA-N 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000006352 cycloaddition reaction Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- OTKCEEWUXHVZQI-UHFFFAOYSA-N 1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(=O)CC1=CC=CC=C1 OTKCEEWUXHVZQI-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical group Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 1
- JEYWNNAZDLFBFF-UHFFFAOYSA-N Nafoxidine Chemical compound C1CC2=CC(OC)=CC=C2C(C=2C=CC(OCCN3CCCC3)=CC=2)=C1C1=CC=CC=C1 JEYWNNAZDLFBFF-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002456 anti-arthritic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- ZKYQRJXGGLVQML-UHFFFAOYSA-N iridium(3+);2-phenylpyridine Chemical compound [Ir+3].C1=CC=CC=C1C1=CC=CC=N1 ZKYQRJXGGLVQML-UHFFFAOYSA-N 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229950002366 nafoxidine Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000001699 photocatalysis Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- HPWDMRBYGBDHTQ-UHFFFAOYSA-M sodium propanoylazanide Chemical group [Na+].CCC([NH-])=O HPWDMRBYGBDHTQ-UHFFFAOYSA-M 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610352476.0A CN105859647B (zh) | 2016-05-25 | 2016-05-25 | 一种环氧合酶‑2抑制剂帕瑞昔布的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610352476.0A CN105859647B (zh) | 2016-05-25 | 2016-05-25 | 一种环氧合酶‑2抑制剂帕瑞昔布的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105859647A CN105859647A (zh) | 2016-08-17 |
CN105859647B true CN105859647B (zh) | 2018-03-27 |
Family
ID=56634783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610352476.0A Active CN105859647B (zh) | 2016-05-25 | 2016-05-25 | 一种环氧合酶‑2抑制剂帕瑞昔布的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105859647B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102625861B1 (ko) | 2016-06-28 | 2024-01-17 | 삼성디스플레이 주식회사 | 헤테로시클릭 화합물 및 이를 포함한 유기 발광 소자 |
CN110256370A (zh) * | 2019-07-01 | 2019-09-20 | 昆药集团股份有限公司 | 一种帕瑞昔布钠的制备方法 |
CN110305071A (zh) * | 2019-07-23 | 2019-10-08 | 成都通德药业有限公司 | 一种帕瑞昔布钠中间体帕瑞昔布的合成方法 |
CN114634457A (zh) * | 2022-04-21 | 2022-06-17 | 济南立德医药技术有限公司 | 一种伐地昔布的精制方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105418528A (zh) * | 2015-12-31 | 2016-03-23 | 山东罗欣药业集团股份有限公司 | 一种帕瑞昔布钠的制备方法 |
-
2016
- 2016-05-25 CN CN201610352476.0A patent/CN105859647B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105418528A (zh) * | 2015-12-31 | 2016-03-23 | 山东罗欣药业集团股份有限公司 | 一种帕瑞昔布钠的制备方法 |
Non-Patent Citations (1)
Title |
---|
帕瑞昔布钠合成路线图解;王凯 等;《中国医药工业杂志》;20130831;第44卷(第8期);第836-838页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105859647A (zh) | 2016-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105859647B (zh) | 一种环氧合酶‑2抑制剂帕瑞昔布的制备方法 | |
Pace et al. | Chemoselective Addition of Halomethyllithiums to Functionalized Isatins: A Straightforward Access to Spiro‐Epoxyoxindoles | |
CN100480234C (zh) | N-(n-苯甲酰基-苯丙氨酰基)-苯丙氨酸二肽衍生物及其制备方法和用途 | |
CN106008387B (zh) | 一种制备环氧合酶-2抑制剂帕瑞昔布的方法 | |
CN106187852A (zh) | 一种富马酸沃诺拉赞中间体的制备方法 | |
CN109134434B (zh) | 喹啉或喹唑啉类化合物及其制备方法和应用 | |
Avila et al. | Acid and base catalyzed Davis–Beirut reaction: experimental and theoretical mechanistic studies and synthesis of novel 3-amino-2H-indazoles | |
CN105294653A (zh) | 富马酸沃诺拉赞的制备工艺 | |
CN107233344B (zh) | 一种抗肿瘤药物依鲁替尼的制备方法 | |
CN105859718B (zh) | 一种铜催化的含氮多杂环化合物的制备方法 | |
CN105418516B (zh) | 一种喹唑啉类化合物及其制备方法 | |
CN110372563A (zh) | 一种温和的取代吡咯磺酰胺脱保护方法 | |
CN110734389B (zh) | 一种二烷基砜类化合物的制备方法 | |
CN101633626B (zh) | L-间氨基苯甘氨酸及其衍生物、制备方法和应用 | |
CN103626791B (zh) | 一种合成3-氨基-4-氟苯硼酸的方法 | |
CN106008386B (zh) | 一种制备用于治疗术后疼痛的帕瑞昔布的方法 | |
CN107163042A (zh) | 一种可用于检测联胺的新型荧光探针的制备工艺 | |
CN106866657A (zh) | 一种麦角新碱的制备方法 | |
CN113583003A (zh) | 一种伐地那非类似物及其合成方法和应用 | |
CN106905177A (zh) | 一种2‑氨基‑3‑联苯基丙酸乙酯衍生物盐酸盐的制备方法 | |
CN111393426A (zh) | 利伐沙班噻吩羧酸酯杂质对照品及其制备方法 | |
CN111333512A (zh) | 阿福拉纳关键中间体4-乙酰基-1-萘甲酸酯的制备 | |
CN105884673B (zh) | 一种吲哚衍生物的合成方法 | |
Raeppel et al. | Novel exploration of the SNAr reaction | |
CN111217842A (zh) | 一类螺环-二吡咯甲烷硼配合物/二吡咯甲川硼配合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Ren Wei Inventor after: Zhang Dan Inventor after: Zhang Heng Inventor after: Zhang Ge Inventor before: Wang Xiaoyue |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20180227 Address after: The 856007 Tibet autonomous region, Naidong District Road No. 86 is the Yalong Bay Garden B District 17 Building No. 1 Applicant after: Tibet hundred year Hank Pharmaceutical Co.,Ltd. Address before: No. 228, Lian Bu Village, Li Zhuang Town, Linyi, Linyi, Shandong Province, 276111 Applicant before: Wang Xiaoyue |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210122 Address after: 401320 Banan District, Banan District, Chongqing, No. 8-29, Yu Nan Road, No. 8-29 Patentee after: Chongqing Boshi Intellectual Property Service Co.,Ltd. Address before: 856007 No.1, building 17, area B, Yalongwan garden, 86 Naidong Road, Naidong District, Shannan City, Tibet Autonomous Region Patentee before: Tibet hundred year Hank Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221021 Address after: 214000 no.1-2201-2, financial 8th Street, Wuxi City, Jiangsu Province Patentee after: Jiangsu intelligent workshop Technology Research Institute Co.,Ltd. Address before: 401320 Banan District, Banan District, Chongqing, No. 8-29, Yu Nan Road, No. 8-29 Patentee before: Chongqing Boshi Intellectual Property Service Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20221129 Address after: 214000 No. 433, East, 4th floor, building 23, science and education software park, Binhu District, Wuxi City, Jiangsu Province Patentee after: Wuxi Defang Biotechnology Co.,Ltd. Address before: 214000 no.1-2201-2, financial 8th Street, Wuxi City, Jiangsu Province Patentee before: Jiangsu intelligent workshop Technology Research Institute Co.,Ltd. |
|
TR01 | Transfer of patent right |